2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow Relapse: new trials by email Literature Review of Relapse trials Research Report on Relapse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies AUR106 - Relapse, Advanced Malignant Neoplasm | Phase 1 | Terminated | Aurigene Discovery Technologies Limited | 21 | 2023-08-26 | 2026-04-17 |
| Ketamine for Relapse Prevention in Recurrent Depressive Disorder Ketamine, Midazolam - Depression, Relapse | Phase 1 | Terminated | St Patrick's Hospital, Ireland | 9 | 2015-12-01 | 2020-01-13 |
Recurrence (2) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Transitional Cell (1) · Colonic Neoplasms (1) · Depression (1) · Depressive Disorder (1) · Depressive Disorder, Major (1) · Esophageal Neoplasms (1) · Kidney Neoplasms (1) · Stomach Neoplasms (1)
Disease Attributes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Behavior (1) · Behavioral Symptoms (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Esophageal Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
Aurigene Discovery Technologies Limited (1) · St Patrick's Hospital, Ireland (1)
India (1) · Ireland (1)
Akhil Kumar, MD (1) · Declan McLoughlin (1)
2015 (1)